Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CURI declined for three days, in 260 of 293 cases, the price declined further within the following month. The odds of a continued downward trend are 89%.
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CURI as a result. In 67 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The Moving Average Convergence Divergence Histogram (MACD) for CURI turned negative on October 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 40 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.
The 10-day moving average for CURI crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CURI's RSI Indicator exited the oversold zone, 33 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 62 cases where CURI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
CURI moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where CURI advanced for three days, in 173 of 216 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
CURI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 120 of 141 cases where CURI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. CURI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.122) is normal, around the industry mean (3.050). CURI's P/E Ratio (1606.560) is considerably higher than the industry average of (112.432). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.298). CURI has a moderately high Dividend Yield (0.118) as compared to the industry average of (0.044). P/S Ratio (2.156) is also within normal values, averaging (8.232).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CURI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.
The Moving Average Convergence Divergence (MACD) for GTN turned positive on October 21, 2026. Looking at past instances where GTN's MACD turned positive, the stock continued to rise in 34 of 41 cases over the following month. The odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 64 cases where GTN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
The 50-day moving average for GTN moved above the 200-day moving average on September 17, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +5.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where GTN advanced for three days, in 206 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Momentum Indicator moved below the 0 level on October 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GTN as a result. In 67 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
GTN moved below its 50-day moving average on October 09, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for GTN crossed bearishly below the 50-day moving average on September 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GTN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
GTN broke above its upper Bollinger Band on October 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for GTN entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.224) is normal, around the industry mean (3.130). P/E Ratio (-7.966) is within average values for comparable stocks, (112.373). Projected Growth (PEG Ratio) (0.122) is also within normal values, averaging (1.298). Dividend Yield (0.069) settles around the average of (0.045) among similar stocks. P/S Ratio (0.148) is also within normal values, averaging (8.232).
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. GTN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GTN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.
CURI | GTN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 70 | 35 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 96 Overvalued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 90 | 91 | |
PRICE GROWTH RATING 1..100 | 57 | 46 | |
P/E GROWTH RATING 1..100 | 6 | 100 | |
SEASONALITY SCORE 1..100 | 90 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GTN's Valuation (11) in the Broadcasting industry is significantly better than the same rating for CURI (96) in the null industry. This means that GTN’s stock grew significantly faster than CURI’s over the last 12 months.
GTN's Profit vs Risk Rating (100) in the Broadcasting industry is in the same range as CURI (100) in the null industry. This means that GTN’s stock grew similarly to CURI’s over the last 12 months.
CURI's SMR Rating (90) in the null industry is in the same range as GTN (91) in the Broadcasting industry. This means that CURI’s stock grew similarly to GTN’s over the last 12 months.
GTN's Price Growth Rating (46) in the Broadcasting industry is in the same range as CURI (57) in the null industry. This means that GTN’s stock grew similarly to CURI’s over the last 12 months.
CURI's P/E Growth Rating (6) in the null industry is significantly better than the same rating for GTN (100) in the Broadcasting industry. This means that CURI’s stock grew significantly faster than GTN’s over the last 12 months.
| CURI | GTN | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 79% | N/A |
| Stochastic ODDS (%) | 1 day ago 81% | 2 days ago 73% |
| Momentum ODDS (%) | 1 day ago 80% | 2 days ago 80% |
| MACD ODDS (%) | 1 day ago 87% | 2 days ago 83% |
| TrendWeek ODDS (%) | 1 day ago 80% | 2 days ago 77% |
| TrendMonth ODDS (%) | 1 day ago 83% | 2 days ago 72% |
| Advances ODDS (%) | 16 days ago 80% | 3 days ago 76% |
| Declines ODDS (%) | 4 days ago 89% | 11 days ago 82% |
| BollingerBands ODDS (%) | 1 day ago 90% | 2 days ago 84% |
| Aroon ODDS (%) | 1 day ago 85% | 2 days ago 81% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CURI’s FA Score shows that 1 FA rating(s) are green while GTN’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CURI’s TA Score shows that 5 TA indicator(s) are bullish while GTN’s TA Score has 4 bullish TA indicator(s).
CURI (@Broadcasting) experienced а +2.21% price change this week, while GTN (@Broadcasting) price change was +6.70% for the same time period.
The average weekly price growth across all stocks in the @Broadcasting industry was +2.04%. For the same industry, the average monthly price growth was -19.68%, and the average quarterly price growth was -26.26%.
CURI is expected to report earnings on Nov 11, 2026.
GTN is expected to report earnings on Nov 06, 2026.
Broadcasting industry includes companies that operate facilities broadcasting radio and/or television programs. Sirius XM Holdings, Inc. (which provides satellite radio and online radio services); Fox Corporation (news and sports broadcasting on TV); and CBS Corporation (TV broadcasting) are some of the behemoths of this industry. The burgeoning digital space has been a disruption for the industry, propelling them to up the ante on their own digital presence.
A.I.dvisor tells us that CURI and SSP have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CURI and SSP's prices will move in lockstep.
| Ticker / NAME | Correlation To CURI | 1D Price Change % | ||
|---|---|---|---|---|
| CURI | 100% | +3.60% | ||
| SSP - CURI | 22% Poorly correlated | +3.11% | ||
| GTN - CURI | 21% Poorly correlated | +1.73% | ||
| BBGI - CURI | 20% Poorly correlated | -6.01% | ||
| NXST - CURI | 17% Poorly correlated | +2.38% | ||
| SGA - CURI | 13% Poorly correlated | N/A | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RITA | 20.15 | 0.06 | +0.32% |
| ETFB Green SRI REITs ETF (RITA) | |||
| SCDV | 25.58 | -0.19 | -0.75% |
| Bahl & Gaynor Small Cap Dividend ETF | |||
| IDUB | 26.66 | -0.36 | -1.34% |
| Aptus International Enhanced Yield (IDUB) | |||
| RBLD | 83.31 | -1.22 | -1.44% |
| First Trust Alerian US NextGen Infrastructure ETF (RBLD) | |||
| FWD | 120.53 | -5.08 | -4.04% |
| AB Disruptors ETF (FWD) | |||